Evidence map›Paper›PMID 23363666›Full record

Trial reportLancet (London, England)2013

Daily chlorhexidine bathing to reduce bacteraemia in critically ill children: a multicentre, cluster-randomised, crossover trial.

Aaron M Milstone, Alexis Elward, Xiaoyan Song, Danielle M Zerr, Rachel Orscheln, Kathleen Speck, Daniel Obeng, Nicholas G Reich, Susan E Coffin, Trish M Perl and 1 more

3 registry-linked trialsAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Lancet (London, England), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 78 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed, 6 pooled it
19.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00549393 phase2 / phase3completednot on this map

Impact of Daily Bathing With Chlorhexidine Impregnated Cloths on Nosocomial Infections in the Pediatric Intensive Care Unit

TypeinterventionalSponsorJohns Hopkins UniversityRan2008 to 2012Enrolled5,659ConditionsNosocomial InfectionsArms2% Chlorhexidine gluconate cloth
NCT02386592 nacompletednot on this mapstarted 2015, after this paper: background citation

Prevention of Nosocomial Bacteremia and Mortality Among Neonates at a Tertiary Referral Center in Zambia

TypeinterventionalSponsorBoston UniversityRan2015 to 2017Enrolled9,410ConditionsNeonatal Sepsis, Neonatal MortalityArmsChlorhexidine gluconate (CHG), Hand hygiene (HH), Infection control training, Infection control reminders via SMS text
NCT02490631 phase3completednot on this mapstarted 2015, after this paper: background citation

A Randomized Controlled Trial of 2% Chlorhexidine Gluconate Skin Preparation Cloths for the Prevention of Post op Surgical Site Infections in Spine Patients (Decrease SSI or DeSSI)

TypeinterventionalSponsorVanderbilt UniversityRan2015 to 2018Enrolled158ConditionsSurgical Site Infections, Post Operative ComplicationArms2% chlorhexidine gluconate cloths
3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 6 syntheses or guidelines pooled it, 217 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Effectiveness of Bath Wipes After Hematopoietic Cell Transplantation: A Randomized Trial.Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses
    Trial
  19. Article
  20. Review

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 1 country.

Aaron M MilstoneDepartment of Pediatrics, Division of Pediatric Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. amilsto1@jhmi.edu
Alexis Elward
Xiaoyan Song
Danielle M Zerr
Rachel Orscheln
Kathleen Speck
Daniel Obeng
Nicholas G Reich
Susan E Coffin
Trish M Perl
Pediatric SCRUB Trial Study Group
Johns Hopkins University · USJohns Hopkins Medicine · USWashington University in St. Louis · USUniversity of Pennsylvania · USUniversity of Washington · USWashington University Medical Center · US

Funding

Institute for Clinical and Translational Research (UL1)UL1RR025005 · NCRR · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2007 to 2011
$75.8M
MRSA in Children: Epidemiology, Pathogenesis, and PreventionK23AI081752 · NIAID · JOHNS HOPKINS UNIVERSITY · PI MILSTONE, AARON M · 2009 to 2012
$538k
NCRR NIH HHS UL1 RR 025005NCRR NIH HHS UL1 RR025005NIAID NIH HHS 1 K23 AI081752NIAID NIH HHS K23 AI081752
6 · The paper itself

Abstract

backgroundBacteraemia is an important cause of morbidity and mortality in critically ill children. Our objective was to assess whether daily bathing in chlorhexidine gluconate (CHG) compared with standard bathing practices would reduce bacteraemia in critically ill children.

methodsIn an unmasked, cluster-randomised, two-period crossover trial, ten paediatric intensive-care units at five hospitals in the USA were randomly assigned a daily bathing routine for admitted patients older than 2 months, either standard bathing practices or using a cloth impregnated with 2% CHG, for a 6-month period. Units switched to the alternative bathing method for a second 6-month period. 6482 admissions were screened for eligibility. The primary outcome was an episode of bacteraemia. We did intention-to-treat (ITT) and per-protocol (PP) analyses. This study is registered with ClinicalTrials.gov (identifier NCT00549393).

findings1521 admitted patients were excluded because their length of stay was less than 2 days, and 14 refused to participate. 4947 admissions were eligible for analysis. In the ITT population, a non-significant reduction in incidence of bacteraemia was noted with CHG bathing (3·52 per 1000 days, 95% CI 2·64-4·61) compared with standard practices (4·93 per 1000 days, 3·91-6·15; adjusted incidence rate ratio [aIRR] 0·71, 95% CI 0·42-1·20). In the PP population, incidence of bacteraemia was lower in patients receiving CHG bathing (3·28 per 1000 days, 2·27-4·58) compared with standard practices (4·93 per 1000 days, 3·91-6·15; aIRR 0·64, 0·42-0·98). No serious study-related adverse events were recorded, and the incidence of CHG-associated skin reactions was 1·2 per 1000 days (95% CI 0·60-2·02).

interpretationCritically ill children receiving daily CHG bathing had a lower incidence of bacteraemia compared with those receiving a standard bathing routine. Furthermore, the treatment was well tolerated.

fundingSage Products, US National Institutes of Health.

Indexed as

BathsAcademic Medical CentersAdministration, TopicalBacteremiaChildChild, PreschoolChlorhexidineCritical IllnessCross InfectionCross-Over StudiesDisinfectantsDrug EruptionsFemaleHospitals, UniversityHumansIncidenceChlorhexidinechlorhexidine gluconateDisinfectants

Identifiers

PMID23363666
PMCPMC4128170
OpenAlexW2155902282

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.